HomeALZN • NASDAQ
Alzamend Neuro Inc
Follow
$0.68
1.81%
After Hours:(4.84%)+0.033
$0.71
Closed: Mar 14, 6:30:05 PM GMT-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.04M | -61.00% |
Net income | -1.04M | 60.96% |
Net profit margin | — | — |
Earnings per share | -0.19 | 95.00% |
EBITDA | -1.02M | 61.29% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.36M | 1,087.18% |
Total assets | 4.18M | 433.53% |
Total liabilities | 725.85K | -84.11% |
Total equity | 3.45M | — |
Shares outstanding | 6.60M | — |
Price to book | 1.15 | — |
Return on assets | -56.48% | — |
Return on capital | -72.01% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -1.04M | 60.96% |
Cash from operations | -1.42M | 29.93% |
Cash from investing | 0.00 | — |
Cash from financing | 688.70K | -67.43% |
Net change in cash | -734.94K | -987.73% |
Free cash flow | -1.08M | -4.66% |
Previous close
$0.69
Day range
$0.64 - $0.70
Year range
$0.64 - $15.06
Market cap
3.68M USD
Avg Volume
602.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
6
